HTG Molecular Diagnostics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,815.30
3,613.40
31,495.50
11,812.60
9,968.60
31,113.60
Total Accounts Receivable
603.90
801.10
716.20
1,377.40
6,356.30
5,012.70
Inventories
744.20
1,475.20
2,201.30
1,511.10
1,180.50
1,306.60
Other Current Assets
164.10
112.00
445.20
433.30
443.10
568.20
Total Current Assets
3,327.40
6,001.80
34,858.30
15,134.40
17,948.50
38,001.10
Net Property, Plant & Equipment
1,070.40
1,357.20
1,932.20
3,270.20
3,304.90
2,373.80
Total Investments and Advances
-
-
2,603.90
-
-
3,270.20
Other Assets
-
1,369.30
-
49.60
3.00
126.10
Total Assets
4,397.80
8,728.20
39,394.40
18,454.20
21,256.30
43,771.30
ST Debt & Current Portion LT Debt
450.00
813.70
3,059.10
6,389.80
5,793.60
Accounts Payable
750.20
948.40
724.80
761.70
2,438.80
Other Current Liabilities
1,202.10
1,541.00
2,535.70
2,869.50
5,109.60
Total Current Liabilities
2,402.30
3,303.10
6,319.60
10,021.00
13,342.00
Long-Term Debt
9,291.20
19,114.10
7,737.60
5,389.10
2,960.80
Other Liabilities
87.90
58.40
8,443.80
8,636.90
8,013.10
Total Liabilities
11,781.50
22,475.60
22,501.00
24,047.10
24,315.80
Common Equity (Total)
58,251.90
69,669.90
16,893.40
5,592.90
3,059.50
Total Shareholders' Equity
7,383.60
13,747.30
16,893.40
5,592.90
3,059.50
Total Equity
7,383.60
13,747.30
16,893.40
5,592.90
3,059.50
Liabilities & Shareholders' Equity
4,397.80
8,728.20
39,394.40
18,454.20
21,256.30
Preferred Stock (Carrying Value)
50,868.30
55,922.60
-
-
-
About HTG Molecular Diagnostics
View Profile
